Aldosterone-induced changes in the cardiac L-type Ca2+ current can be prevented by antioxidants in vitro and are absent in rats on low salt diet

Pflugers Archiv European Journal of Physiology

Volumn 457, Issue 2, 2008, Pages 339-349

  Wagner, Michael ^a   Rudakova, Elena ^a   Volk, Tilmann ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aldosterone; Calcium current; Cardiac electrophysiology; Corticosterone; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALDOSTERONE; ANTIOXIDANT; CALCIUM CHANNEL L TYPE; CORTICOSTEROID; CORTICOSTERONE; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROPHYSIOLOGY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MALE; MUSCLE CELL; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SODIUM RESTRICTION;

ACETYLCYSTEINE; ACTION POTENTIALS; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; ANTIOXIDANTS; CALCIUM CHANNELS, L-TYPE; CORTICOSTERONE; DIET, SODIUM-RESTRICTED; ELECTROCARDIOGRAPHY; HEART RATE; HEART VENTRICLES; KINETICS; MALE; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ALDOSTERONE; SPIRONOLACTONE; TIME FACTORS;

EID: 56649097460     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-008-0518-1     Document Type: Article

References (47)

1. AA Armoundas R Wu G Juang E Marban GF Tomaselli 2001 Electrical and structural remodeling of the failing ventricle Pharmacol Ther 92 213 230
2. DP Zipes HJ Wellens 1998 Sudden cardiac death Circulation 98 2334 2351
3. 2+ current in adult rat cardiomyocytes Circ Res 85 1139 1145
4. + current density in rat ventricular myocytes J Physiol 537 151 160
5. E Perrier BG Kerfant N Lalevee P Bideaux MF Rossier S Richard AM Gomez JP Benitah 2004 Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction Circulation 110 776 783
6. 2+ current in mice J Physiol 569 153 162
7. + transport Br J Nutr 73 633 640
8. RM Krauss RH Eckel B Howard LJ Appel SR Daniels RJ Deckelbaum JW Erdman Jr P Kris-Etherton IJ Goldberg TA Kotchen AH Lichtenstein WE Mitch R Mullis K Robinson J Wylie-Rosett S St Jeor J Suttie DL Tribble TL Bazzarre 2000 AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association Circulation 102 2284 2299
9. M Schroth C Plank M Rauh HG Dorr W Rascher J Dotsch 2006 Pediatric renal allograft transplantation does not normalize the increased cortisol/cortisone ratios of chronic renal failure Eur J Endocrinol 154 555 561
10. G Isenberg U Klöckner 1982 Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium" Pflügers Arch 395 6 18
11. + currents among the left ventricular wall of rats with ascending aortic stenosis J Physiol 530 443 455
12. OP Hamill A Marty E Neher B Sakmann FJ Sigworth 1981 Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches Pflügers Arch 391 85 100
13. 2+ current characteristics in endo- and epicardial myocytes from rat left ventricle with pressure-induced hypertrophy Pflügers Arch 443 399 404
14. JS Rougier O Muller S Berger G Centeno G Schutz D Firsov H Abriel 2008 Mineralocorticoid receptor is essential for corticosteroid-induced up-regulation of L-type calcium currents in cultured neonatal cardiomyocytes Pflügers Arch 456 2 407 412
15. SM Bryant SJ Shipsey G Hart 1999 Normal regional distribution of membrane current density in rat left ventricle is altered in catecholamine-induced hypertrophy Cardiovasc Res 42 391 401
16. J Tytgat J Vereecke E Carmeliet 1990 A combined study of sodium current and T-type calcium current in isolated cardiac cells Pflügers Arch 417 142 148
17. 2+ channels in ventricular cells from hypertrophied rat hearts J Mol Cell Cardiol 31 1617 1625
18. N Lalevee MC Rebsamen S Barrere-Lemaire E Perrier J Nargeot JP Benitah MF Rossier 2005 Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes Cardiovasc Res 67 216 224
19. RB Clark RA Bouchard SE Salinas CJ Sanchez WR Giles 1993 Heterogeneity of action potential waveforms and potassium currents in rat ventricle Cardiovasc Res 27 1795 1799
20. 2+ influx in rat cardiac myocytes of endo- and epicardial origin J Physiol 519 841 850
21. JW Funder 2005 Mineralocorticoid receptors: distribution and activation Heart Fail Rev 10 15 22
22. JS Silvestre V Robert B Escoubet C Heymes A Oubenaissa C Desopper B Swynghedauw C Delcayre 2000 Different regulation of cardiac and renal corticosteroid receptors in aldosterone-salt treated rats: effect of hypertension and glucocorticoids J Mol Cell Cardiol 32 1249 1263
23. JL Arriza RB Simerly LW Swanson RM Evans 1988 The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response Neuron 1 887 900
24. M Lombes S Kenouch A Souque N Farman ME Rafestin-Oblin 1994 The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase Endocrinology 135 834 840
25. D Pearce KR Yamamoto 1993 Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element Science 259 1161 1165
26. SM Deneke 2000 Thiol-based antioxidants Curr Top Cell Regul 36 151 180
27. 2+- and protein kinase C-dependent mechanism Am J Physiol Heart Circ Physiol 280 H1528 H1536
28. TJ Kamp JW Hell 2000 Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C Circ Res 87 1095 1102
29. B Couette V Marsaud EE Baulieu H Richard-Foy ME Rafestin-Oblin 1992 Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter Endocrinology 130 430 436
30. M de Gasparo U Joss HP Ramjoue SE Whitebread H Haenni L Schenkel C Kraehenbuehl M Biollaz J Grob J Schmidlin 1987 Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro J Pharmacol Exp Ther 240 650 656
31. CY Chang PJ Walther DP McDonnell 2001 Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer Cancer Res 61 8712 8717
32. A Ouvrard-Pascaud Y Sainte-Marie JP Benitah R Perrier C Soukaseum AN Cat A Royer K Le Quang F Charpentier S Demolombe F Mechta-Grigoriou AT Beggah P Maison-Blanche ME Oblin C Delcayre GI Fishman N Farman B Escoubet F Jaisser 2005 Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias Circulation 111 3025 3033
33. RS Kass ML Blair 1981 Effects of angiotensin II on membrane current in cardiac Purkinje fibers J Mol Cell Cardiol 13 797 809
34. + current in rat ventricular myocytes Proc Natl Acad Sci U S A 85 8756 8760
35. to in epicardial and endocardial ventricular myocytes from the canine heart Circ Res 86 1062 1068
36. JL Arriza C Weinberger G Cerelli TM Glaser BL Handelin DE Housman RM Evans 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor Science 237 268 275
37. K Myles JW Funder 1994 Type I (mineralocorticoid) receptors in the guinea pig Am J Physiol 267 E268 E272
38. JW Funder PT Pearce R Smith AI Smith 1988 Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated Science 242 583 585
39. AL Albiston VR Obeyesekere RE Smith ZS Krozowski 1994 Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme Mol Cell Endocrinol 105 R11 R17
40. CG Brilla KT Weber 1992 Mineralocorticoid excess, dietary sodium, and myocardial fibrosis J Lab Clin Med 120 893 901
41. K Nagata K Obata J Xu S Ichihara A Noda H Kimata T Kato H Izawa T Murohara M Yokota 2006 Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats Hypertension 47 656 664
42. AC Kulkarni P Kuppusamy N Parinandi 2007 Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy Antioxid Redox Signal 9 1717 1730
43. C Kitiyakara T Chabrashvili Y Chen J Blau A Karber S Aslam WJ Welch CS Wilcox 2003 Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase J Am Soc Nephrol 14 2775 2782
44. N Engberding S Spiekermann A Schaefer A Heineke A Wiencke M Muller M Fuchs D Hilfiker-Kleiner B Hornig H Drexler U Landmesser 2004 Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug Circulation 110 2175 2179
45. K Yoshida S Kim-Mitsuyama R Wake Y Izumiya Y Izumi T Yukimura M Ueda M Yoshiyama H Iwao 2005 Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress Hypertens Res 28 447 455
46. B Pitt F Zannad WJ Remme R Cody A Castaigne A Perez J Palensky J Wittes 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 709 717
47. JW Funder 2004 Is aldosterone bad for the heart Trends Endocrinol Metab 15 139 142